| （単位：千ドル） | 3Q19 | 1Q20 | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 11,040 | 14,252 | 13,839 | 12,133 | 12,423 | 15,966 | 14,813 | 8,107 | 6,662 | 8,106 | 7,272 | 7,561 | 6,093 | 1,488 | 1,430 | 305 | 93 |
| 営業利益 | -12,856 | -17,818 | -17,713 | -16,078 | -17,481 | -21,088 | -20,300 | -13,154 | -11,955 | -12,959 | -13,881 | -16,807 | -13,396 | -4,577 | -4,209 | -5,908 | -1,963 |
| 経常（税引前）利益 | -13,351 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -5,784 | - |
| 法人税等合計 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -203 | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - |
| 純利益 | -13,351 | -18,417 | -18,657 | -17,078 | -18,715 | -22,386 | -22,626 | -15,443 | -14,558 | -16,033 | -17,710 | -20,712 | -15,073 | -4,381 | -4,064 | -5,581 | -1,592 |
| 一株あたり利益 | - | - | - | - | - | - | - | - | -0.54 | -0.6 | -0.5 | -0.48 | -0.33 | -0.08 | -0.07 | -0.1 | -0.01 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | -0.54 | -0.6 | -0.5 | 0.48 | -0.33 | -0.08 | -0.07 | -0.1 | -0.01 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | -4,568 | - | - | - |